Sirona Biochem (CVE:SBM) Stock Price Down 16.7% – Here’s Why

Shares of Sirona Biochem Corp. (CVE:SBM) fell 16.7% during mid-day trading on Tuesday . The stock traded as low as C$0.05 and last traded at C$0.05. 113,000 shares traded hands during trading, an increase of 113% from the average session volume of 53,014 shares. The stock had previously closed at C$0.06.

Sirona Biochem Stock Down 16.7 %

The company has a quick ratio of 2.41, a current ratio of 0.34 and a debt-to-equity ratio of 219.21. The firm has a market cap of C$12.84 million, a price-to-earnings ratio of -5.00 and a beta of -0.03. The firm has a fifty day moving average price of C$0.06 and a 200-day moving average price of C$0.06.

About Sirona Biochem

Sirona Biochem Corp., a cosmetic ingredient and drug discovery company, develops and sells cosmetic and pharmaceutical active ingredients in Canada and France. Its programs include cosmetic skin lightener and diabetes drug; and other projects comprise the development of an anti-aging/cell protection library, novel anti-wrinkle compound, and anti-viral program.